Source BioScience Expands Genomic Footprint
Pathology Reimagined: New digital pathology model
Source BioScience completes £18.5m strategic acquisition of LDPath Ltd to reimagine the future of pathology by combining cellular and digital pathology platforms
Integrated storage and delivery solutions from Source BioScience provide a reliable solution for distribution of the COVID 19 vaccine
Oxford Nanopore and SourceBio announce commercial partnership for UK COVID-19 testing service
Source Bioscience UK Ltd offer NHS COVID-19 testing
Source BioScience to use PrimeStore MTM kits for COVID-19 testing service
Source BioScience, an Established Provider of Testing Services to the NHS, Secures Overnight Funding to Enable It to Accelerate Its Offering of COVID-19 Testing for Frontline Workers
